Skip to main content

Advertisement

Log in

Health-Related Quality of Life in Adults with Osteogenesis Imperfecta

  • Original Research
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

Osteogenesis imperfecta (OI) is a systemic connective tissue disorder most often caused by mutations in collagen type 1 related genes. Patients with OI suffer from multiple fractures and various degrees of growth deficiency and bone deformity. It is unknown whether the systemic effect of defect collagen type 1 influences the quality of life in patients with OI. We therefore aimed to investigate health-related quality of life (HRQoL) in a well-characterized cohort of adult patients with OI. We included 85 adult patients with mild to severe OI (types I, III, and IV) and obtained information about skeletal- and non-skeletal phenotypes and patient demographics. We investigated physical and mental HRQoL using a validated questionnaire, SF-36, and compared the data to values obtained in a population without OI. Patients with mild, moderate, and severe OI all had lower mean scores on domains describing physical HRQoL and a lower mean physical component score compared to the general population, p < 0.001. Patients with severe OI had lower mean scores on physical HRQoL, p < 0.05. The scores on domains reflecting mental HRQoL were more inhomogenously affected, but did not differ significantly from the general population. OI has an impact on physical and some aspects of mental HRQoL. The scores on physical health were correlated to severity of the OI disease. The mental component score in the OI patients was unaffected and comparable with the general population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Glorieux FH (2008) Osteogenesis imperfecta. Best Pract Res Clin Rheumatol 22:85–100

    Article  CAS  PubMed  Google Scholar 

  2. Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16:101–116

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Folkestad L, Hald JD, Ersboll AK, Gram J, Hermann AP, Langdahl B, Abrahamsen B (2016) Brixen K. A Nationwide Register-Based Cohort Study. J Bone Miner Res, Fracture Rates and Fracture Sites in Patients With Osteogenesis Imperfecta, p 10

    Google Scholar 

  4. van Dijk FS, Sillence DO (2014) Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A 164A:1470–1481

    Article  PubMed  Google Scholar 

  5. Chevrel G, Meunier PJ (2001) Osteogenesis imperfecta: lifelong management is imperative and feasible. Joint Bone Spine 68:125–129

    Article  CAS  PubMed  Google Scholar 

  6. Paterson CR, McAllion S, Stellman JL (1984) Osteogenesis imperfecta after the menopause. N Engl J Med 310:1694–1696

    Article  CAS  PubMed  Google Scholar 

  7. Rauch F, Glorieux FH (2004) Osteogenesis imperfecta. Lancet 363:1377–1385

    Article  CAS  PubMed  Google Scholar 

  8. Bishop NJ, Walsh JS (2014) Osteogenesis imperfecta in adults. J Clin Investig 124(2):476

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Bishop N (2010) Characterising and treating osteogenesis imperfecta. Early Hum Dev 86:743–746

    Article  PubMed  Google Scholar 

  10. Balkefors V, Mattsson E, Pernow Y, Saaf M (2013) Functioning and quality of life in adults with mild-to-moderate osteogenesis imperfecta. Physiother Res Int 18:203–211

    Article  PubMed  Google Scholar 

  11. Wekre LL, Froslie KF, Haugen L, Falch JA (2010) A population-based study of demographical variables and ability to perform activities of daily living in adults with osteogenesis imperfecta. Disabil Rehabil 32:579–587

    Article  PubMed  Google Scholar 

  12. Staquet M, Hays R, Fayers P (1998) Quality of life assessment in clinical trials; methods and practice. Oxford University Press, Oxford

    Google Scholar 

  13. Widmann RF, Laplaza FJ, Bitan FD, Brooks CE, Root L (2002) Quality of life in osteogenesis imperfecta. Int Orthop 26:3–6

    Article  PubMed  Google Scholar 

  14. Forestier-Zhang L, Watts L, Turner A, Teare H, Kaye J, Barrett J, Cooper C, Eastell R, Wordsworth P, Javaid MK, Pinedo-Villanueva R (2016) Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia. Orphanet J Rare Dis 11:160

    Article  PubMed  PubMed Central  Google Scholar 

  15. han-Oliel N, Oliel S, Tsimicalis A, Montpetit K, Rauch F, Dogba MJ (2016) Quality of life in osteogenesis imperfecta: A mixed-methods systematic review. Am J Med Genet A 170:62–76

    Article  Google Scholar 

  16. Widmann RF, Bitan FD, Laplaza FJ, Burke SW, DiMaio MF, Schneider R (1999) Spinal deformity, pulmonary compromise, and quality of life in osteogenesis imperfecta. Spine 24:1673–1678

    Article  CAS  PubMed  Google Scholar 

  17. Dogba MJ, Bedos C, Durigova M, Montpetit K, Wong T, Glorieux FH, Rauch F (2013) The impact of severe osteogenesis imperfecta on the lives of young patients and their parents—a qualitative analysis. BMC Pediatr 13:153. doi:10.1186/1471-2431-13-153.:153-13

    Article  PubMed  PubMed Central  Google Scholar 

  18. Rauch F, Lalic L, Roughley P, Glorieux FH (2010) Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta. J Bone Miner Res 25:1367–1374

    CAS  PubMed  Google Scholar 

  19. Hald JD, Folkestad L, Harslof T, Lund AM, Duno M, Jensen JB, Neghabat S, Brixen K, Langdahl B (2016) Skeletal phenotypes in adult patients with osteogenesis imperfecta-correlations with COL1A1/COL1A2 genotype and collagen structure. Osteoporos Int 27(11):3331–3341

    Article  CAS  PubMed  Google Scholar 

  20. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. conceptual framework and item selection. Med Care 30:473–483

    Article  PubMed  Google Scholar 

  21. Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A (1995) Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 33:AS264–AS279

    Article  PubMed  Google Scholar 

  22. Bjorner JB, Thunedborg K, Kristensen TS, Modvig J, Bech P (1998) The Danish SF-36 Health Survey: translation and preliminary validity studies. J Clin Epidemiol 51:991–999

    Article  CAS  PubMed  Google Scholar 

  23. Bjorner JB, Damsgaard MT, Watt T, Groenvold M (1998) Tests of data quality, scaling assumptions, and reliability of the Danish SF-36. J Clin Epidemiol 51:1001–1011

    Article  CAS  PubMed  Google Scholar 

  24. Ablon J (2003) Personality and stereotype in osteogenesis imperfecta: behavioral phenotype or response to life’s hard challenges? Am J Med Genet A 122A:201–214

    Article  PubMed  Google Scholar 

  25. Reite M, Davis K, Solomons C, Ott J (1972) Osteogenesis imperfecta: psychological function. Am J Psychiatry 128:1540–1546

    Article  CAS  PubMed  Google Scholar 

  26. Ose D, Rochon J, Campbell SM, Wensing M, Freund T, van LJ, Langst G, Szecsenyi J, Ludt S (2014) Health-related quality of life and risk factor control: the importance of educational level in prevention of cardiovascular diseases. Eur J Public Health 24:679–684

    Article  PubMed  Google Scholar 

  27. de Putter CE, Selles RW, Haagsma JA, Polinder S, Panneman MJ, Hovius SE, Burdorf A, van Beeck EF (2014) Health-related quality of life after upper extremity injuries and predictors for suboptimal outcome. Injury 45(11):1752–1758

    Article  PubMed  Google Scholar 

  28. Peric’ S, Rakocevic-Stojanovic V, Stevic Z, Basta I, Pavlovic S, Vujanac V, Marjanovic L, Lavrnic D (2010) Health-related quality of life in patients with myotonic dystrophy type 1 and amyotrophic lateral sclerosis. Acta Neurol Belg 110:71–77

    PubMed  Google Scholar 

  29. Al-Shehri AH, Taha AZ, Bahnassy AA, Salah M (2008) Health-related quality of life in type 2 diabetic patients. Ann Saudi Med 28:352–360

    Article  PubMed  Google Scholar 

  30. van der Slot WM, Nieuwenhuijsen C, van den Berg-Emons RJ, Wensink-Boonstra AE, Stam HJ, Roebroeck ME (2010) Participation and health-related quality of life in adults with spastic bilateral cerebral palsy and the role of self-efficacy. J Rehabil Med 42:528–535

    Article  PubMed  Google Scholar 

  31. Bertoletti J, Marx GC, Hattge Junior SP, Pellanda LC (2014) Quality of life and congenital heart disease in childhood and adolescence. Arq Bras Cardiol 102:192–198

    PubMed  PubMed Central  Google Scholar 

  32. Albrecht GL, Devlieger PJ (1999) The disability paradox: high quality of life against all odds. Soc Sci Med 48:977–988

    Article  CAS  PubMed  Google Scholar 

  33. Bandura A (2004) Health promotion by social cognitive means. Health Educ Behav 31:143–164

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Dorte Haubek and Hans Gjørup for performing dental examinations, Christer Zøylner Swan and Jens Wanscher for performing audiologic evaluations, and Christian-Heinrich Leonhard for performing eye examinations. Grant supporters: Central Region of Denmark, Osteoporoseforeningen, Denmark

Author information

Authors and Affiliations

Authors

Contributions

Author Contributions

JDH, TH, and BL designed the study. JDH conducted the study and prepared the first draft of the paper. JDH is responsible for statistical analysis of the data. All authors contributed substantially, revised the paper critically, and approved the final version of the paper. JDH is the guarantor.

Corresponding author

Correspondence to Jannie Dahl Hald.

Ethics declarations

Conflict of interest

LF reports having received speaker fees from Genzymes and AstraZeneca. TH reports having received speaker fees from Amgen. BL reports advisory board membership and having received speaking fees from Amgen, Eli Lilly, Merck, and UCB and research support from Eli Lilly, Novo Nordisk, and Orkla Health. KB reports having received grants from MSD, Novartis, Amgen, and NPS. JDH has no interests to declare.

Human and Animal Rights and Informed Consent

The study complied with ethical standards of research involving human participants and was approved by the Danish Ethical Committee (ref-number M-20100108). Informed consent was obtained from all patients.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hald, J.D., Folkestad, L., Harsløf, T. et al. Health-Related Quality of Life in Adults with Osteogenesis Imperfecta. Calcif Tissue Int 101, 473–478 (2017). https://doi.org/10.1007/s00223-017-0301-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-017-0301-4

Keywords

Navigation